sidered to improve postoperative survival [1] [2] [3] . A recent trend in the treatment of early gastric cancer, however, involves less invasive or limited surgery to improve the patient's quality of life [4] [5] [6] . Recent investigations have reported that micrometastases to lymph nodes that were overlooked by ordinary hematoxylin and eosin (H&E) staining could be detected by cytokeratin (CK) immunostaining, and these so-called micrometastases were found to have prognostic significance [7] [8] [9] [10] . Mucosal gastric cancer (m-cancer) has been the prime candidate for less invasive surgery or endoscopic mucosal resection (EMR) [11, 12] . However, the frequency or outcome of occult involvement in lymph nodes from m-cancer remains unclear. In this study, in order to assess the critical indications for EMR or less invasive surgery for m-cancer, we investigated the incidence of micrometastasis in lymph nodes in mcancer, using CK immunostaining.
Introduction
In patients with gastric cancer, metastasis to lymph nodes has been recognized as the most important factor in prognosis, and lymphadenectomy has long been conOffprint requests to: J. Cai Received: May 17, 2000 / Accepted: July 14, 2000 pathology of the Japanese Research Society for Gastric Cancer [13] . For the purpose of describing tumor location, we divided the gastric area into three equal regions: the upper-third, the middle-third, and the lower-third. Tumor size was determined based on the maximum superficial diameter of the lesion. Macroscopic types were described as 0-I, protruded; 0-IIa, superficial elevated; 0-IIb, flat; 0-IIc, superficial depressed; and 0-III, excavated.
A total of 2526 lymph nodes dissected from the 84 patients were investigated in the present study. The mean number of dissected lymph nodes per patient was 30 (range, 10-61 nodes). All samples were fixed in formalin and embedded in paraffin. Two consecutive sections, of 4-µm-thickness, were prepared from each sample. One section was stained with H&E and the other was subjected to CK specific immunostaining. Eight lymph nodes with metastatic cancer cells detected by H&E staining were used as positive controls, and 40 perigastric nodes obtained from 15 patients with benign gastric ulcer were used as negative controls.
Immunohistochemical staining was performed by the streptavidin-biotin (SAB) immunoperoxidase method with murine monoclonal antibody CAM 5.2 (Becton Dickinson, San Jose, CA, USA), which specifically recognizes intracellular CK components numbers 8 and 18 [14] . Briefly, dewaxed and dehydrated sections were heated in a microwave oven (700 W) for 10 min for the retrieval of antigens in the specimens. Endogenous peroxidase was blocked by incubation of the samples with 3% hydrogen peroxide in methanol. The tissue sections were incubated with the primary monoclonal antibody, CAM 5.2, at 25 µg per ml overnight at 4°C. The second antibodies, biotinylated antibodies against mouse immunoglobulin, were applied, followed by the application of peroxidase-labeled streptavidin. The reaction products were visualized with diaminobenzidine as the chromogen, and sections were counterstained with methyl green.
The H&E-stained slides were first assessed for the presence of metastases, at a magnification of 200ϫ, by an experienced pathologist without the knowledge of sample groupings and previous diagnosis. Then the immunostained slides were examined, and the results were compared with those obtained from the H&E-stained slides. Micrometastasis in lymph nodes was recognized when tumor cells were detected only by CKspecific immunostaining, having been overlooked after ordinary H&E staining.
Statistical analysis was performed by the 2 test to examine the differences between CK immunostaining and the clinicopathological characteristics of the primary tumors. A P value of less than 0.05 was considered an indication of statistical significance.
Results

Features of nodal involvement
Metastases in lymph nodes were confirmed by ordinary H&E staining in 8 lymph nodes from only one patient (1.2%). All 8 nodes were CK-positive; in addition, another 9 lymph nodes of this patient were shown to be cancer-positive by CK immunostaining. Micrometastases were also detected in 28 lymph nodes from 15 other patients (18%), none of whom were observed to have metastases by conventional H&E staining. Thus, the frequency of lymph node involvement in relation to the total number of dissected lymph nodes was increased, from 0.3% (8/2526 nodes) with H&E staining, to 1.8% (45/2526 nodes) with CK immunostaining (P Ͻ 0.0001). The incidence of nodal involvement in all 84 patients with m-cancer was increased, from 1.2% (1/84 patients) with H&E staining, to 19% (16/84 patients) with CK immunostaining (P Ͻ 0.05). The clinicopathological characteristics of these 16 patients with lymph node involvement are shown in Table 1 . In these 16 patients with metastasis or micrometastasis, a single cancer cell was detected in the lymph node in 9 patients (56%), two or more discrete cancer cells were detected in the lymph node in 2 patients (13%; Fig. 1a ), and clustered cancer cells were detected in the lymph node in 5 patients (31%; Fig. 1b ). In the patient with lymph node metastasis evidenced by H&E staining, large clustered cancer cells were located in the medullar and marginal sinus of the lymph nodes. By contrast, micrometastasized cancer cells detected by CK immunostaining were found to be located in the marginal sinus in the form of a single cell, or discrete cells, or small cell clusters.
Cancer-positive lymph nodes were detected only in group 1 nodes in 11 patients, and 8 of these patients were found to have only a single cancer cell in their lymph nodes. Cancer-positive lymph nodes were detected in group 2 or 3 nodes in 5 patients, and 4 of these 5 patients had discrete or clustered cancer cells in their lymph nodes. Of these 5 patients with extra-perigastric lymph node involvement, 2 patients had micrometastasis only in group 3 lymph nodes, but did not show any involvement in any of the group 1 or 2 lymph nodes. One of these two rare tumors with only group 3 lymph node micrometastasis was located in the lesser curvature of the middle-third of the stomach, with only a single CK-positive cell in the station 8p lymph node. The other of these rare tumors was located in the greater curvature of the middle-third of the stomach, with one cluster of CK-positive cells in each of the station 2 and 4sa lymph nodes. An additional 10 consecutive sections of station 3, 1, 7, and 8a lymph nodes in the former patient, and station 4sb, 4d, and 3 lymph nodes in the latter patient, were cut again from the remaining half of the lymph node blocks and immunostained, but no CK-positive cells were found in any of these lymph nodes. No CK-positive lymph node was found in any of the 20 lymph nodes from benign gastric ulcer patients (negative controls).
Association with clinicopathological characteristics
We compared the clinicopathological factors in the 16 patients with and the 68 patients without nodal involvement. More nodal involvement occurred in tumors larger than 1.0 cm in superficial diameter (21%), then in those with depressed macroscopic type (IIc or III; 23%) and in those with ulcer formation (36%), but no Macroscopic type, according to reference [13] b Histological type, according to reference [13] cally, the incidence of lymph node metastasis in mucosal gastric cancer has been reported as 1.3% to 5.0% [11, 12, [15] [16] [17] . Recently, it has been reported that mcancer with a tumor smaller than 2 cm in diameter, of the well differentiated type or the elevated macroscopic type, has no lymph node metastasis. Thus, for patients with this type of m-cancer, EMR or limited lymphadenectomy has generally been performed [4, 5, 11] . Micrometastasis of lymph nodes in such patients with m-cancer has not been well discussed. Lymph node metastases are known to be one of the most important prognostic factors [15] [16] [17] [18] . Maehara et al. [7] and Ishida et al. [8] reported that patients with micrometastasis in the lymph nodes showed poor prognosis. Our previous investigations in advanced [9] and in submucosal gastric cancers [10] also estimated an unfavorable outcome in patients with lymph node micrometastasis. In the present study, we investigated a sufficiently large number of lymph nodes (2526) from 84 patients with mcancer by cytokeratin (CK) immunostaining, and the incidence of micrometastasis in lymph nodes was found to be 18% in patients with cancer-negative lymph nodes a According to reference [13] significant difference was found ( Table 2 ). Six of the 9 patients with only a single cancer cell in the lymph nodes had tumors smaller than or equal to 2 cm, while all 7 (100%) patients with discrete or clustered cancer cells in the lymph nodes had tumors larger than 2 cm in diameter (P ϭ 0.0239; Table 3 ). All 5 patients with group 2 or 3 lymph node involvement had tumors larger than 2 cm (P ϭ 0.0367). In addition, the number of involved lymph nodes was much higher in patients with tumors larger than 2 cm than in those with tumors smaller than or equal to 2 cm (P ϭ 0.0367). One of our 84 patients with m-cancer who died of peritoneal dissemination was postoperatively found to have micrometastasis in group 2 lymph nodes, in the form of clustered cancer cells. There was no postoperative recurrence in the patients without lymph node involvement.
Discussion
Traditional D2 lymphadenectomy is widely used for patients with early gastric cancer in Japan. Histologi- shown by ordinary H&E staining. This incidence is significantly higher than that reported by ordinary H&E staining.
Whether a single cancer cell in the regional lymph node can have clinicopathological significance remains unclear. Discrete or large clusters of cancer cells were frequently found in H&E-positive lymph nodes. By comparison, 9 of 15 patients were shown to have micrometastasis by CK immunostaining on the basis of only a single cancer cell in their lymph nodes, and in all but 1 of these patients, only the group 1 lymph node was involved. These cases of micrometastases seem to be at a very early stage of tumor invasion to the lymph nodes. Histological research has shown a very low incidence of postoperative recurrence in patients with m-cancer [19] . Whether these micrometastasized single cells in lymph nodes are subsequently removed by the immune response of the host is still unclear [8] .
Tumor size has been reported to be one of the risk factors for lymph node metastasis [10, 20] . In the present study, we found that tumors larger than 2 cm frequently showed micrometastasis in the form of discrete or clustered cancer cells in lymph nodes. Moreover, we found that tumors larger than 2 cm were much more likely to invade the distant lymph nodes such as those in group 2 or 3. These findings indicate that m-cancers with tumors larger than 2 cm are at risk for micrometastasis in lymph nodes far from the primary tumors. The present study demonstrated that a considerable number of small mcancers with tumors of 1-2 cm, in fact, had micrometastasis in the lymph nodes. Therefore, patients with m-cancer with a tumor larger than 1.0 cm may have lymph node involvement, which possibility should be given due consideration.
Lymph node metastasis has been observed mainly in perigastric nodes in m-and submucosal (sm)-cancers, although jumping metastases to extra-perigastric lymph nodes have been reported histologically in early gastric cancer [17, 21] . In our study, two patients showed micrometastasis in the group 3 lymph nodes, but not in any of the group 1 or 2 lymph nodes. An additional ten consecutive sections from the perigastric lymph nodes of each of these two patients were checked in detail, but no additional cancer cells were found. Therefore, two patients with jumping micrometastases in distant lymph nodes were shown in the present study. Both of these patients had undifferentiated tumors larger than 4.5 cm in diameter. Jumping micrometastasis of lymph nodes shown by CK immunostaining appears to occur more frequently than has been previously reported histologically in m-cancers [21] [22] [23] .
Recently, EMR or limited lymphadenectomy has been performed for patients with m-cancer. Because mcancer with a tumor larger than 1.0 cm in superficial diameter has a risk of micrometastasis to the lymph nodes, EMR is not recommended for these patients.
